Sort
10,766 grants matching “checkpoint inhibitor”
Novel Mechano-Acoustic Enhancement of Immunotherapy
$184,740Ahmed El Kaffas · Stanford University · R21 · FY2022 · CA
Metabolic reprogramming to improve EGFRvIII CAR T cell persistence
$184,717John H Sampson · Duke University · R21 · FY2021 · CA
Deciphering the System-Wide Immune Response to Head and Neck Cancer
$184,680Kyle B Jones · University Of California, San Francisco · K23 · FY2020 · DE
Deciphering the System-Wide Immune Response to Head and Neck Cancer
$184,680Kyle B Jones · University Of California, San Francisco · K23 · FY2019 · DE
Deciphering the System-Wide Immune Response to Head and Neck Cancer
$184,680Kyle B Jones · University Of California, San Francisco · K23 · FY2021 · DE
Directed Purinergic Signaling as Immunotherapy in Leukemia
$184,603Simon C Robson · Beth Israel Deaconess Medical Center · R21 · FY2019 · CA
Investigating Mechanisms of Hyperprogression on Anti-PD-1 Immunotherapy
$184,371Andrew B. Sharabi · University Of California, San Diego · R21 · FY2021 · CA
Bronchoscopic Cryo-Immunotherapy of Lung Cancer
$184,331Daniel Sterman · New York University School Of Medicine · R21 · FY2021 · CA
Evaluation of TERT promoter mutations as melanoma biomarkers in tumors and plasma
$184,331David Polsky · New York University School Of Medicine · R21 · FY2015 · CA
Immune-Cancer Cell Interactions in a 3D Bioprinted Tumor Microenvironment
$184,295Derya Unutmaz · Jackson Laboratory · R21 · FY2019 · CA
Phase 2 Irinotecan for Treatment of p53 WT Gastric Adenocarcinoma
$184,266Manish A Shah · Sloan-Kettering Inst Can Research · R01 · FY2010 · FD
First in Class Small molecules to simultaneously inhibit protein translation and an immune checkpoint in cancers
$184,185France Carrier · University Of Maryland Baltimore · R01 · FY2025 · CA
INTRACELLULAR CA2+ HOMEOSTASIS AND CELLULAR RADIOSENSITIVITY
$184,121Virginia Commonwealth University · P01 · FY2001 · CA
Project 2: Transcriptional Dynamics and Temporal Reprogramming During Radiation Treatment
$183,964Jacob Gardinier Scott · Cleveland Clinic Lerner Com-Cwru · U54 · FY2024 · CA
CORRELATIVE SCIENCE CORE
$183,900Jon C Aster · Brigham And Women'S Hospital · P50 · FY2017 · CA
Inducing Tumor Neoantigens Through RNA Editing for Cancer Immunotherapy
$183,782Jeffrey A. Hubbell · University Of Chicago · R21 · FY2024 · CA
Improving decision-making in patients with resectable melanoma and pre-existing autoimmune disease considering immune checkpoint inhibition
$183,625Maria De Los Angeles Lopez-Olivo · University Of Tx Md Anderson Can Ctr · K08 · FY2021 · CA
Reprogramming myeloid cells by JAK inhibition to enhance checkpoint blockade therapy
$183,600Jaroslav Zak · Utah State Higher Education System--University Of Utah · K22 · FY2025 · CA
Evaluation of a therapeutic vaccination strategy with motif neoepitope peptide-pulsed autologous dendritic cells for non-small cell lung cancer patients harboring a charged HLA-B binding pocket.
$183,494Edward B Garon · University Of California Los Angeles · R21 · FY2023 · CA
Chemical platform to produce covalent biologics
$183,405Alexander V Statsyuk · University Of Houston · R21 · FY2023 · GM
Targeting mitochondrial oxygen demand to overcome hypoxic immune privilege of NSCLC tumors
$183,398Martin Benej · Ohio State University · K22 · FY2025 · CA
Targeting mitochondrial oxygen demand to overcome hypoxic immune privilege of NSCLC tumors
$183,398Martin Benej · Ohio State University · K22 · FY2024 · CA
Immunomodulation by dietary protein restriction
$183,372Roberto Pili · Indiana University Indianapolis · R21 · FY2018 · CA
Rapid evaluation of immunotherapy regimens in ex vivo human pancreatic tumor slice cultures.
$183,261Hidayatullah G Munshi · Northwestern University At Chicago · R21 · FY2022 · CA
Project 3: The Functional Contribution of Tumor Immunity in PDAC
$183,081Raghu Kalluri · University Of Tx Md Anderson Can Ctr · P01 · FY2017 · CA